arrow
J

Jeffrey Seow

king's college london
H指数:29
被引数:6,002

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Geographical Differences in SARS-CoV-2 Antibody Response Dynamics and Neutralisation Profiles to Mild COVID-19: Lessons from a UK-Uganda Comparison

SARS-CoV-2抗体应答动力学及中和表型在轻度COVID-19中的地理差异:来自英国-乌干达比较的启示

2025-03-210
OA
Long-Term Immune Consequences of Initial SARS-CoV-2 A.23.1 Exposure: A Longitudinal Study of Antibody Responses and Cross-Neutralization in a Ugandan Cohort

初始SARS-CoV-2 A.23.1暴露的长期免疫后果: 乌干达队列中抗体反应和交叉中和的纵向研究

2025-01-290
OAAI
Antibody levels following vaccination against SARS-CoV-2: associations with post-vaccination infection and risk factors in two UK longitudinal studies

接种SARS-CoV-2疫苗后的抗体水平: 两项英国纵向研究中疫苗接种后感染和危险因素的关联

2023-01-2415
OAAI
Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19
2022-08-0910
OAAI
SARS-CoV-2 host-shutoff impacts innate NK cell functions, but antibody-dependent NK activity is strongly activated through non-spike antibodies

SARS-CoV-2宿主关闭影响先天NK细胞功能,但抗体依赖性NK活性通过非刺突抗体强烈激活

2022-05-1940
OA
Neutralizing antibody activity in convalescent sera from infection in humans with SARS-CoV-2 and variants of concern
2021-10-150
OAAI
Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B.1.1.7 variant
IMMUNITY
IF26.3
2021-06-0199
OAAI
SARS-CoV-2 can recruit a heme metabolite to evade antibody immunity
2021-05-2887
OAAI
Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
LEUKEMIA
IF13.4
2021-05-2241
OAAI
The effect of spike mutations on SARS-CoV-2 neutralization
2021-03-01162
OAAI